These projects were made possible from Cure Alzheimer's Fund support.
Project Description | Researchers | Funding |
---|---|---|
Alzheimer’s Disease Tau Consortium: The Role of Amyloid Beta-Induced Membrane Damage in Tau Pathology |
2024 $286,558.79 |
|
Alzheimer’s Disease Tau Consortium: The Role of Amyloid Beta-Induced Membrane Damage in Tau Pathology |
2022, 2023 $572,804.65 |
These published papers resulted from Cure Alzheimer’s Fund support.
Sadleir, K. R., Gomez, K. P., Edwards, A. E., Patel, A. J., Ley, M. L., Khatri, A. W., Guo, J., Mahesh, S., Watkins, E. A., Popovic, J., Karunakaran, D. K. P., Prokopenko, D., Tanzi, R. E., Bustos, B., Lubbe, S. J., Demonbruen, A. R., McNally, E. M., & Vassar, R. Annexin A6 membrane repair protein protects against amyloid-induced dystrophic neurites and tau phosphorylation in Alzheimer’s disease model mice, Acta Neuropathologica, May 24, 2025, Read More
Chandra, S., Popovic, J., Singhal, N. K., Watkins, E. A., Dodiya, H. B., Weigle, I. Q., Salvo, M. A., Ramakrishnan, A., Chen, Z., Watson, J. T., Shetti, A., Piehl, N., Zhang, X., Cuddy, L. K., Sadleir, K. R., Schwulst, S. J., Prakriya, M., Gate, D., Sisodia, S. S., & Vassar, R. The gut microbiome controls reactive astrocytosis during Aβ amyloidosis via propionate-mediated regulation of IL-17, The Journal of Clinical Investigation, May 13, 2025, Read More